Literature DB >> 12624715

A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions.

F Carella1, M Bressanelli, S Piacentini, P Soliveri, G Geminiani, D Monza, A Albanese, F Girotti.   

Abstract

The so-called bradykinesia of Huntington's disease (HD) seems not due to reduced movement speed alone but may also be task-dependent. We therefore investigated the influence of visual control on the ability of HD patients to perform a motor task. Ten HD patients, never treated with neuroleptic drugs and with mild functional impairment in activities of daily living, performed the task blindfolded and not blindfolded, as did 10 age- and education-matched healthy controls. The task was to use the dominant hand to trace out the contours of a 20 x 20 cm square in a clockwise direction, pausing at each corner. The square was marked on the table at which the subject sat. Accuracy was stressed rather than speed. A videocamerabased system recorded movement trajectories, from which kinematic and error parameters were derived. Patients and controls moved at comparable speeds but patients took longer to complete the task due to more curvilinear and hence longer trajectories. Patients spent more time in the deceleration phase of the movement, and in the blindfold condition had more variable movements as indicated by greater error variability scores. Correlation analysis showed that kinematic parameters in patients did not correlate with involuntary movement scores. These findings indicate that abnormalities of motor control are present in HD when movement accuracy (and not velocity) is required. HD patients are more dependent on visual control than normal subjects.

Entities:  

Mesh:

Year:  2003        PMID: 12624715     DOI: 10.1007/s100720300003

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Variability in interval production is due to timing-dependent deficits in Huntington's disease.

Authors:  Ashwini K Rao; Karen S Marder; Jasim Uddin; Brian C Rakitin
Journal:  Mov Disord       Date:  2014-08-22       Impact factor: 10.338

2.  Speed-Accuracy Trade-Off in a Trajectory-Constrained Self-Feeding Task: A Quantitative Index of Unsuppressed Motor Noise in Children With Dystonia.

Authors:  Francesca Lunardini; Matteo Bertucco; Claudia Casellato; Nasir Bhanpuri; Alessandra Pedrocchi; Terence D Sanger
Journal:  J Child Neurol       Date:  2015-04-20       Impact factor: 1.987

Review 3.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

4.  Sensorimotor mapping affects movement correction deficits in early Huntington's disease.

Authors:  M Lemay; E Fimbel; A Beuter; S Chouinard; F Richer
Journal:  Exp Brain Res       Date:  2005-05-05       Impact factor: 1.972

5.  Coordination of fingertip forces during precision grip in premanifest Huntington's disease.

Authors:  Ashwini K Rao; Andrew M Gordon; Karen S Marder
Journal:  Mov Disord       Date:  2011-03-10       Impact factor: 10.338

6.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

7.  Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.

Authors:  Véronique Gaura; Sonia Lavisse; Pierre Payoux; Serge Goldman; Christophe Verny; Pierre Krystkowiak; Philippe Damier; Frédéric Supiot; Anne-Catherine Bachoud-Levi; Philippe Remy
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

8.  Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues.

Authors:  Jessica Despard; Anne-Marie Ternes; Bleydy Dimech-Betancourt; Govinda Poudel; Andrew Churchyard; Nellie Georgiou-Karistianis
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.